What is Pitavastatin?
Pitavastatin is a prescription medication that belongs to a class of drugs called statins, also known as HMG-CoA reductase inhibitors. It is primarily used to lower cholesterol levels and reduce the risk of cardiovascular disease in adults. Pitavastatin is one of the newer statins, offering effective cholesterol management with a unique metabolism profile.
Uses
Primary hyperlipidemia and mixed dyslipidemia: Pitavastatin is prescribed to reduce elevated total cholesterol, LDL cholesterol, and triglyceride levels while increasing HDL (good) cholesterol in patients with various forms of high cholesterol.
Cardiovascular disease prevention: The medication helps reduce the risk of heart attack, stroke, and other cardiovascular events in patients with elevated cholesterol levels or existing risk factors.
Familial hypercholesterolemia: It can be used to treat inherited conditions that cause extremely high cholesterol levels, often in combination with dietary changes and other lifestyle modifications.
Secondary prevention: For patients who have already experienced cardiovascular events, pitavastatin may be prescribed as part of a comprehensive treatment plan to prevent future complications.
Diabetes-related dyslipidemia: The medication can help manage abnormal cholesterol patterns commonly seen in patients with type 2 diabetes.
How it works
Pitavastatin works by blocking an enzyme called HMG-CoA reductase, which is responsible for producing cholesterol in the liver. By inhibiting this enzyme, the medication reduces the liver’s ability to make cholesterol, forcing the body to remove cholesterol from the bloodstream to meet its needs. This dual action results in lower blood cholesterol levels and improved cardiovascular health outcomes.
Side effects
Common side effects:
- Muscle pain or weakness
- Joint pain
- Headache
- Nausea
- Constipation
- Diarrhea
- Upper respiratory tract infections
- Dizziness
Serious side effects:
- Rhabdomyolysis (severe muscle breakdown that can cause kidney damage)
- Liver problems, including elevated liver enzymes
- Severe allergic reactions
- New-onset diabetes or worsening of existing diabetes
- Memory problems or confusion
Warnings and precautions
Muscle problems: Patients should be monitored for signs of muscle pain, tenderness, or weakness, especially when starting treatment or increasing doses. The risk increases with higher doses and certain drug combinations.
Liver function: Regular liver function tests may be recommended, particularly in patients with a history of liver disease or those consuming substantial amounts of alcohol.
Pregnancy and breastfeeding: Pitavastatin should not be used during pregnancy or while breastfeeding, as cholesterol is essential for fetal development and the drug may pass into breast milk.
Kidney impairment: Patients with severe kidney disease may require dose adjustments or alternative treatments, as reduced kidney function can affect drug clearance.
Age considerations: Elderly patients may be more susceptible to side effects and may require lower starting doses or more frequent monitoring.
Interactions
Cyclosporine: This immunosuppressive drug significantly increases pitavastatin levels, requiring dose adjustments or alternative treatments.
Rifampin: This antibiotic can reduce pitavastatin effectiveness by increasing its breakdown in the body.
Gemfibrozil: This cholesterol medication increases the risk of muscle problems when combined with pitavastatin.
Warfarin: Pitavastatin may enhance the blood-thinning effects of warfarin, requiring more frequent monitoring of clotting times.
Niacin: High doses of niacin combined with statins may increase the risk of muscle-related side effects.
Grapefruit juice: Unlike some other statins, pitavastatin has minimal interaction with grapefruit juice, but moderation is still recommended.
Antacids: Taking aluminum or magnesium-containing antacids may reduce pitavastatin absorption if taken simultaneously.
Colchicine: This gout medication may increase the risk of muscle problems when used with pitavastatin.
Check interactions with the GMJ Interaction Checker
Dosage
The typical starting dose for adults is 2 mg once daily, taken with or without food. Depending on individual response and cholesterol levels, the dose may be increased to a maximum of 4 mg daily. Some patients may start with 1 mg daily if they are at higher risk for side effects or have certain medical conditions. Dosage adjustments may be necessary for patients with kidney problems or those taking interacting medications. Healthcare providers will determine the appropriate dose based on individual patient factors, cholesterol targets, and response to treatment.
Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.
Cite this page
GMJ News Desk. "Pitavastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/pitavastatin/
This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).Was this article helpful?


